Hiru
The first multi-platform eye tracker in the world
User Manual | Quick Start Guide: Windows
User Manual IRISBOND Hiru Eye Tracking System
IRISBOND CROWDBONDING, S.L. All rights reserved.
This document, including all supporting materials, is proprietary to IRISBOND CROWDBONDING, S.L.
As this document may contain information that is confidential, proprietary, or otherwise legally protected, it must not be further copied, distributed, or displayed without the express written permission of IRISBOND CROWDBONDING, S.L.
Products that are referred to in this document may be either trademarks and/or registered trademarks of the respective owners. The publisher and the author make no claim to these trademarks.
Contact Information
IRISBOND CROWDBONDING, S.L
Tolosa Avenue 75, 2nd floor
20018 Donostia-San Sebastián, Gipuzkoa, Spain
+34 943 496 622
Update Hiru in iOS
Check out this video for more information.
Software requirements
Hiru app needs to be at a minimum version of 2.8.
Hiru needs to have a license for iOS. If you don’t have a license for Hiru, contact your provider.
Steps to update
In Hiru App, when a new version is available, the “Update Hiru” Button will appear in the upper right corner in blue. Click here, then click “Upgrade Hiru”. Leave the Hiru plugged in while the Update completes. Click “Cancel Upgrade” to stop this process.
CE & MDR | Technical Specifications
Compliance Information: CE and MDR
Compliance Information: CE and MDR
| MANUFACTURER | IRISBOND CROWDBONDING, SL VAT: ES-B75091058 ADDRESS: AVENIDA DE TOLOSA, 75 – 2º |
| APPLICABLE DIRECTIVE | COUNCIL DIRECTIVE 93/42/EEC of 14 June 1993 concerning medical devices |
| HARMONIZED STANDARDS | EN 55032 (2015) / AC (2016) / A11 (2020) EN 55035 (2017): UNE-EN 62471-1:2009 FCC CFR 47, Part 15, Subpart B (10-1-15 Edition) ICES-003 Issue 6 (2016) |
| PRODUCT | Sistema de control del ordenador con la mirada HIRU/ Eye tracking system HIRU |
| REFERENCE | IRISBOND HIRU |
| TEST CERTIFICATES | 65321IEM.001 65321REM.001 65321REM.002 2251989-PHO-21-018A |
The device model has been designed and manufactured in conformity with the Directive.
Eduardo Jauregui / Technical Director
Declaration of conformity (MDR)
We, Irisbond Crowdbonding Ltd, declare that the product listed below has been designed and manufactured in conformity with the Directive (UE) 2017/745:
| MANUFACTURER | IRISBOND CROWDBONDING, SL ES-B75091058 AVENIDA DE TOLOSA, 75 – 2º +34 9434 96 622 http://www.irisbond.com |
| REFERENCE | IRISBOND HIRU |
| PRODUCT | Eye-tracking system HIRU |
The aim of this declaration is a Class I Medical Device and is in conformity with the following harmonized legislation:
| APPLICABLE DIRECTIVE | • Directive (UE) 2017/745 concerning medical devices, MDR. • EMC Directive, 2004/108/EC. • RoHS Directive, 2011/65/EU. • FCC Rules and Regulations. |
The following harmonized standards and technical specifications have been applied:
| HARMONIZED LEGISLATION | EN 55032 (2015) / AC (2016) / A11 (2020) EN 55035 (2017) UNE-EN 62471-1:2009 FCC CFR 47, Part 15, Subpart B (10-1-15 Edition) ICES-003 Issue 6 (2016) |
| TEST CERTIFICATES | 65321IEM.001 65321REM.001 65321REM.002 2251989-PHO-21-018A |
This declaration is signed on behalf of Irisbond Crowdbonding, Ltd in San Sebastián, on the 30th of April, 2021, by Eduardo Jauregui, CEO.
Declaration of conformity (MDR)
We, Irisbond Crowdbonding Ltd, declare that the product listed below has been designed and manufactured in conformity with the Directive (UE) 2017/745:
| MANUFACTURER | IRISBOND CROWDBONDING, SL ES-B75091058 AVENIDA DE TOLOSA, 75 – 2 +34 9434 96 622 http://www.irisbond.com |
| REFERENCE | OSKOL WINDOWS |
| PRODUCT | This product is composed of the following elements: • Medical device; Eye-tracking system HIRU. • Case to bundle the Irisbond HIRU eye tracker and the Surface Pro tablet (TPU material has PASSED skin sensitization and cytotoxicity tests in accordance with ISO 10993-5 and 10993-10). |
The aim of this declaration is a Class I Medical Device and is in conformity with the following directives:
| APPLICABLE DIRECTIVE | REGULATION (EU) 2017/745 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 5 April 2017 on medical devices, MRD, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directive 90/385/EEC. |
The following harmonized standards and technical specifications have been applied:
| HARMONIZED LEGISLATION | HIRU: EN 55032: 2015 / AC: 2016 / A11: 2020 EN 55035: 2017 UNE-EN 62471-1:2009 FCC CFR 47, Part 15, Subpart B (10-1-15 Edition) ICES-003 Issue 6: 2016 OSKOL Windows: ISO 10993-5 ISO 10993-10 |
| TEST CERTIFICATES | 65321IEM.001 65321REM.001 65321REM.002 2251989-PHO-21-018A |
This declaration is signed on behalf of Irisbond Crowdbonding, Ltd in San Sebastián, on the 30th of April, 2021, by Eduardo Jauregui, CEO.
Declaration of conformity (MDR)
We, Irisbond Crowdbonding Ltd, declare that the product listed below has been designed and manufactured in conformity with the Directive (UE) 2017/745:
| MANUFACTURER | IRISBOND CROWDBONDING, SL ES-B75091058 AVENIDA DE TOLOSA, 75 – 2º San Sebastián, 20018 Guipúzcoa, Spain +34 9434 96 622 http://www.irisbond.com |
| REFERENCE | OSKOL iPad |
| PRODUCT | This product is composed of the following elements: • Eye tracking system HIRU, medical device class I. • Case to bundle the Irisbond HIRU eye tracker and the iPad Pro tablet (TPU material has PASSED skin sensitization and cytotoxicity tests in accordance with ISO 10993-5 and 10993-10) |
The aim of this declaration is a Class I Medical Device and is in conformity with the following harmonized legislation:
| APPLICABLE DIRECTIVE | REGULATION (EU) 2017/745 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 5 April 2017 concerning medical devices, MDR, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directive 90/385/EEC. |
The following harmonized and/or unharmonized standards and technical specifications have been applied:
|
HARMONIZED LEGISLATION | HIRU: EN 55032: 2015 / AC: 2016 / A11: 2020 EN 55035: 2017 UNE-EN 62471-1:2009 FCC CFR 47, Part 15, Subpart B (10-1-15 Edition) ICES-003 Issue 6: 2016 OSKOL iPad: ISO 10993-5 ISO 10993-10 |
| TEST CERTIFICATES | 65321IEM.001 65321REM.001 65321REM.002 2251989-PHO-21-018A |
This declaration is signed on behalf of Irisbond Crowdbonding, Ltd in San Sebastián, on the 30th of April, 2021, by Eduardo Jauregui, CEO.
Technical Specifications
| Optimum screen size | 10-20” |
| Recommended working distance | 35-80 cm. |
| Calibration | 0, 1, 5, 9, 16 points |
| Selection mode | Dwell, Blink, Switch |
| Headbox | 20 x 18 cm. at 50 cm. |
| Eye-tracking | Monocular and binocular |
| Accuracy | 0.4º |
| Sampling rate (Frequency) | 60 Hz. |
| Mounting | Holder, magnets, or specific adaptor for a consumer device |
| Operating system | Windows: 7-10 iPadOS: 13 or above Others: Please get in touch with us |
| Eye Tracking processing | Hiru on-chip eye-tracking technology |
| Minimum system requirements (laptop, PC, tablet) | Eye-tracking processing is done at HIRU itself. System requirements related to the applications used with HIRU. Typically: • USB 3.0 -C • 1,33 GHz CPU • 2 GB RAM • 3GB + HDD Hard Disk • Intel Graphics, Nvidia, and others with OpenGL 2.0 • iOS: iPad Pro |
| Weight | 115 g. |
| Dimensions | 259 x 25 x 28 mm. |
| Eye-tracking technology | Dark pupil |
| USB connector | USB-C |
See it Possible
Avenida de Tolosa, 75. Floor 2
Donostia San-Sebastián. 20018 Gipuzkoa
Spain +34 943 49 66 22
www.irisbond.com
[email protected]
IRISBOND | Eye-tracking interactivo, descubre el potencial de tu mirada
